Market overview
The global extracorporeal membrane oxygenation machine market is worth USD 405 mn in 2026 and is forecast to reach USD 796 mn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Stationary consoles is the largest by type segment.
| Scope | Console systems that pump and oxygenate blood outside the body for severe heart or lung failure: stationary and portable ECMO machines, sold to hospitals and transport services. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 380 mn |
| Value 2026 | USD 405 mn |
| Value 2036 | USD 796 mn |
| CAGR 2026-2036 | 7.0% |
| Volume 2026 | 4,239 units |
| Volume 2036 | 7,933 units |
| Average price 2026 | USD 95,480 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Extracorporeal Membrane Oxygenation Machine market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 405 mn |
| 2027 | USD 433 mn |
| 2028 | USD 463 mn |
| 2029 | USD 496 mn |
| 2030 | USD 530 mn |
| 2031 | USD 568 mn |
| 2032 | USD 607 mn |
| 2033 | USD 650 mn |
| 2034 | USD 695 mn |
| 2035 | USD 744 mn |
| 2036 | USD 796 mn |
Extracorporeal Membrane Oxygenation Machine market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Stationary consoles | 50.0% | 40.5% | USD 202 mn | 4.8% |
| Portable and transport systems | 36.0% | 44.4% | USD 146 mn | 9.3% |
| Compact and neonatal systems | 14.0% | 15.0% | USD 57 mn | 7.8% |
By clinical use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Respiratory support | 46.0% | 42.1% | USD 186 mn | 6.1% |
| Cardiac support | 38.0% | 34.8% | USD 154 mn | 6.1% |
| Extracorporeal CPR | 16.0% | 23.1% | USD 65 mn | 11.0% |
By support mode
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Venovenous | 44.0% | 45.0% | USD 178 mn | 7.2% |
| Venoarterial | 48.0% | 47.0% | USD 194 mn | 6.8% |
| Hybrid and other | 8.0% | 8.0% | USD 32 mn | 7.0% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 60.0% | 55.0% | USD 243 mn | 6.1% |
| Specialty cardiac and ECMO centres | 28.0% | 30.0% | USD 113 mn | 7.7% |
| Mobile and transport services | 12.0% | 15.0% | USD 49 mn | 9.4% |
By pump technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Centrifugal | 76.0% | 74.0% | USD 308 mn | 6.7% |
| Roller | 12.0% | 10.0% | USD 49 mn | 5.1% |
| Magnetically levitated | 12.0% | 16.0% | USD 49 mn | 10.1% |
Top 25 countries for extracorporeal membrane oxygenation machine by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 95.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 130 mn | 32.0% | USD 254 mn | 7.0% |
| 2 | China | USD 57 mn | 14.0% | USD 134 mn | 9.0% |
| 3 | Germany | USD 36 mn | 9.0% | USD 65 mn | 6.0% |
| 4 | Japan | USD 28 mn | 7.0% | USD 49 mn | 5.5% |
| 5 | France | USD 20 mn | 5.0% | USD 36 mn | 5.9% |
| 6 | Italy | USD 16 mn | 4.0% | USD 28 mn | 5.6% |
| 7 | United Kingdom | USD 16 mn | 4.0% | USD 30 mn | 6.5% |
| 8 | Brazil | USD 12 mn | 3.0% | USD 26 mn | 8.0% |
| 9 | Spain | USD 12 mn | 3.0% | USD 21 mn | 5.9% |
| 10 | South Korea | USD 12 mn | 3.0% | USD 26 mn | 8.0% |
| 11 | Canada | USD 5.5 mn | 1.4% | USD 9.9 mn | 6.1% |
| 12 | India | USD 4.8 mn | 1.2% | USD 13 mn | 10.5% |
| 13 | Australia | USD 4.8 mn | 1.2% | USD 8.7 mn | 6.2% |
| 14 | Turkey | USD 4.1 mn | 1.0% | USD 9.3 mn | 8.6% |
| 15 | Netherlands | USD 3.4 mn | 0.8% | USD 6.2 mn | 6.1% |
| 16 | Switzerland | USD 3.4 mn | 0.8% | USD 6.2 mn | 6.1% |
| 17 | Saudi Arabia | USD 3.4 mn | 0.8% | USD 7.7 mn | 8.4% |
| 18 | Belgium | USD 2.8 mn | 0.7% | USD 4.9 mn | 6.0% |
| 19 | Mexico | USD 2.8 mn | 0.7% | USD 6.2 mn | 8.5% |
| 20 | Taiwan | USD 2.8 mn | 0.7% | USD 4.9 mn | 6.0% |
| 21 | Poland | USD 2.1 mn | 0.5% | USD 3.7 mn | 6.1% |
| 22 | Sweden | USD 2.1 mn | 0.5% | USD 3.7 mn | 6.1% |
| 23 | Austria | USD 2.1 mn | 0.5% | USD 3.7 mn | 6.1% |
| 24 | Russia | USD 2.1 mn | 0.5% | USD 3.7 mn | 6.1% |
| 25 | Israel | USD 2.1 mn | 0.5% | USD 3.7 mn | 6.1% |
| Rest of world | USD 17 mn | 4.1% | USD 31 mn | 6.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Getinge
- LivaNova
- Medtronic
Group 2: Regional and specialist players
- Xenios
- Terumo
- Eurosets
- Cardiac Assist
- Chalice Medical
Group 3: Emerging and niche players
- Spectrum Medical
- Hemovent
- Lifebridge Medizintechnik
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the extracorporeal membrane oxygenation machine market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.0% is calculated from the resulting values.
The market is divided by type, by clinical use, by support mode, by end user, by pump technology. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the extracorporeal membrane oxygenation machine market?
The global extracorporeal membrane oxygenation machine market is estimated at USD 380 mn in 2025 and USD 405 mn in 2026.
How fast will the extracorporeal membrane oxygenation machine market grow?
It is forecast to reach USD 796 mn by 2036, a compound annual growth rate of 7.0% from 2026, an increase of USD 391 mn.
Which country is the largest market for extracorporeal membrane oxygenation machine?
United States is the largest market by revenue at USD 130 mn in 2026, 32.0% of the global total. The three largest countries together hold 55.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 9.0% a year from 2026 to 2036.
Which extracorporeal membrane oxygenation machine segment is largest?
In the by type split, Stationary consoles is the largest segment with 50.0% of 2026 revenue.
Who are the leading extracorporeal membrane oxygenation machine companies?
Global leaders include Getinge, LivaNova, Medtronic.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Swine Disease Diagnostic KitUSD 405 mn · 6.2% CAGR
- Wound Care SurfactantUSD 405 mn · 6.2% CAGR
- NICU Modular NutritionUSD 403 mn · 5.8% CAGR
- Advanced Humidification IncubatorUSD 401 mn · 5.5% CAGR
- UV-C Disinfection RobotsUSD 382 mn · 7.0% CAGR
- AI-Assisted Clinical Trial Protocol DesignUSD 378 mn · 20.0% CAGR
- Mixed Reality Navigation PlatformsUSD 378 mn · 17.0% CAGR
- AI enhanced Mammography ScreeningUSD 434 mn · 19.0% CAGR
← Extended-Action Local Anaesthetic Extracorporeal Membrane Oxygenation →